TrialDiabetes, obesity & metabolism2025

Treatment satisfaction and time in range after 16 weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes.

Viral N Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.